Article

jdsupra.com on 2023-03-23 19:55

FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations

On March 15, 2023, the U.S. Food and Drug Administration (“FDA”) issued updated draft guidance, Electronic Systems, Electronic Records, and Electronic ...

Greenville

Related news

FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations jdsupra.com
Greenville
FDA Finalizes Quality Recommendations for Cannabis in Clinical Investigations jdsupra.com
Electric boogaloo: FDA releases sequel to 2003 guidance on use of electronic records and electronic signatures in clinical investigations jdsupra.com
United States
FDA Finalizes Informed Consent Guidance for Drug and Medical Device Clinical Investigations jdsupra.com
FDA Draft Guidance Addresses Electronic Informed Consent in Clinical Investigations jdsupra.com
FDA Issues Final Guidance on Informed Consent in Clinical Investigations jdsupra.com
FDA Issues Recommendations on COVID-19 Drug Development and Clinical Trials for Regulatory Approval jdsupra.com
Conduct of Clinical Trials During the COVID-19 Pandemic: Recommendations from FDA jdsupra.com
California , United States , Switzerland
FDA details recommendations for live case presentations during medical device clinical trials in final guidance jdsupra.com
California , United States , Switzerland
The ABCs of DCTs: New FDA Guidance Provides Recommendations for the Conduct of Decentralized Clinical Trials jdsupra.com
FDA Publishes Informed Consent Final Guidance for Drug and Medical Device Clinical Investigations jdsupra.com
FDA issues guidance on the use of EHRs in clinical investigations jdsupra.com
A Pandemic Silver Lining: FDA’s New Guidance on Using Digital Health Technologies for Clinical Investigations jdsupra.com
FDA Draft Guidance Regarding Inclusion of Pregnant Women in Clinical Trials jdsupra.com
California , United States , Switzerland
FDA’s Final Q&A Guidance on Risk-Based Monitoring of Clinical Trials Provides Additional Recommendations for Sponsors jdsupra.com
FDA Issues Final Rule Permitting IRB Waiver or Alteration of Informed Consent for Certain Minimal Risk Clinical Investigations jdsupra.com
Cures , Reg
FDA Issues New Guidance on IRB Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations jdsupra.com
Cures
Panel revises harvest recommendations for spiny dogfish TimesDaily.com
CDC Revises Quarantine (Following Close Contact) Recommendations jdsupra.com